

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | auditory receptor cell differentiation (GO:0042491) | 4.71279244 |
| 2 | neutrophil activation involved in immune response (GO:0002283) | 4.50806838 |
| 3 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.46738777 |
| 4 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 4.29619325 |
| 5 | negative regulation of complement activation (GO:0045916) | 4.26962434 |
| 6 | production of molecular mediator involved in inflammatory response (GO:0002532) | 4.15618449 |
| 7 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.11174102 |
| 8 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.11174102 |
| 9 | modulation by symbiont of host immune response (GO:0052553) | 4.11174102 |
| 10 | positive regulation by symbiont of host defense response (GO:0052509) | 4.11174102 |
| 11 | modulation by symbiont of host defense response (GO:0052031) | 4.11174102 |
| 12 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.11174102 |
| 13 | regulation of glucokinase activity (GO:0033131) | 4.10519515 |
| 14 | regulation of hexokinase activity (GO:1903299) | 4.10519515 |
| 15 | signal peptide processing (GO:0006465) | 4.05262356 |
| 16 | eosinophil chemotaxis (GO:0048245) | 4.00767331 |
| 17 | respiratory burst (GO:0045730) | 3.87372029 |
| 18 | response to peptidoglycan (GO:0032494) | 3.86543594 |
| 19 | negative regulation of protein activation cascade (GO:2000258) | 3.85878589 |
| 20 | keratan sulfate catabolic process (GO:0042340) | 3.85689630 |
| 21 | Golgi transport vesicle coating (GO:0048200) | 3.76691192 |
| 22 | COPI coating of Golgi vesicle (GO:0048205) | 3.76691192 |
| 23 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.70981081 |
| 24 | inositol phosphate catabolic process (GO:0071545) | 3.59395775 |
| 25 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 3.58270655 |
| 26 | inositol phosphate dephosphorylation (GO:0046855) | 3.58270655 |
| 27 | eosinophil migration (GO:0072677) | 3.57769724 |
| 28 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.57743592 |
| 29 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.57743592 |
| 30 | positive regulation of interferon-alpha production (GO:0032727) | 3.56630640 |
| 31 | angiotensin maturation (GO:0002003) | 3.56064055 |
| 32 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.54213694 |
| 33 | cellular extravasation (GO:0045123) | 3.47032933 |
| 34 | endocrine pancreas development (GO:0031018) | 3.45949913 |
| 35 | macrophage activation involved in immune response (GO:0002281) | 3.45596310 |
| 36 | regulation of B cell apoptotic process (GO:0002902) | 3.45503352 |
| 37 | regulation of interferon-alpha production (GO:0032647) | 3.43393812 |
| 38 | negative regulation of humoral immune response (GO:0002921) | 3.38354752 |
| 39 | neutrophil activation (GO:0042119) | 3.37399972 |
| 40 | response to type I interferon (GO:0034340) | 3.32610044 |
| 41 | detection of molecule of bacterial origin (GO:0032490) | 3.31516167 |
| 42 | granulocyte activation (GO:0036230) | 3.29062528 |
| 43 | cellular response to type I interferon (GO:0071357) | 3.28155992 |
| 44 | type I interferon signaling pathway (GO:0060337) | 3.28155992 |
| 45 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.27515967 |
| 46 | positive regulation of glycolytic process (GO:0045821) | 3.23597533 |
| 47 | positive regulation of mast cell activation (GO:0033005) | 3.23135179 |
| 48 | positive regulation of mast cell degranulation (GO:0043306) | 3.21837105 |
| 49 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.21837105 |
| 50 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.17822250 |
| 51 | negative regulation of acute inflammatory response (GO:0002674) | 3.14737662 |
| 52 | insulin secretion (GO:0030073) | 3.13769964 |
| 53 | cellular ketone body metabolic process (GO:0046950) | 3.12296389 |
| 54 | lipoxygenase pathway (GO:0019372) | 3.11413689 |
| 55 | polyol catabolic process (GO:0046174) | 3.08764863 |
| 56 | reactive oxygen species biosynthetic process (GO:1903409) | 3.08602153 |
| 57 | inositol phosphate-mediated signaling (GO:0048016) | 3.07034070 |
| 58 | keratinocyte development (GO:0003334) | 3.06954532 |
| 59 | negative regulation of execution phase of apoptosis (GO:1900118) | 3.04840820 |
| 60 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.01877968 |
| 61 | regulation of mast cell degranulation (GO:0043304) | 3.01140068 |
| 62 | regulation of mast cell activation (GO:0033003) | 3.00253353 |
| 63 | endosome to melanosome transport (GO:0035646) | 2.99664708 |
| 64 | endosome to pigment granule transport (GO:0043485) | 2.99664708 |
| 65 | positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:00357 | 2.98982659 |
| 66 | nitric oxide biosynthetic process (GO:0006809) | 2.97230506 |
| 67 | positive regulation of histone H3-K4 methylation (GO:0051571) | 2.95273638 |
| 68 | early endosome to late endosome transport (GO:0045022) | 2.95109515 |
| 69 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.92439503 |
| 70 | definitive hemopoiesis (GO:0060216) | 2.90154669 |
| 71 | ketone body metabolic process (GO:1902224) | 2.89761689 |
| 72 | positive regulation of antigen processing and presentation (GO:0002579) | 2.88720105 |
| 73 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.87357996 |
| 74 | protein retention in ER lumen (GO:0006621) | 2.86176719 |
| 75 | detection of external biotic stimulus (GO:0098581) | 2.86077656 |
| 76 | imidazole-containing compound metabolic process (GO:0052803) | 2.85684299 |
| 77 | positive regulation of protein autophosphorylation (GO:0031954) | 2.85618418 |
| 78 | estrogen metabolic process (GO:0008210) | 2.84964579 |
| 79 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.83113108 |
| 80 | response to host immune response (GO:0052572) | 2.81780503 |
| 81 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.81780503 |
| 82 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.81065463 |
| 83 | regulation of protein glycosylation (GO:0060049) | 2.80098355 |
| 84 | macrophage activation (GO:0042116) | 2.80078064 |
| 85 | immunoglobulin mediated immune response (GO:0016064) | 2.79508762 |
| 86 | sequestering of metal ion (GO:0051238) | 2.79236238 |
| 87 | response to hydroperoxide (GO:0033194) | 2.77104813 |
| 88 | oligosaccharide catabolic process (GO:0009313) | 2.76802658 |
| 89 | regulation of mononuclear cell migration (GO:0071675) | 2.76627658 |
| 90 | nodal signaling pathway (GO:0038092) | 2.75470102 |
| 91 | xenobiotic catabolic process (GO:0042178) | 2.75096532 |
| 92 | myeloid cell activation involved in immune response (GO:0002275) | 2.74763149 |
| 93 | glycerophospholipid catabolic process (GO:0046475) | 2.74376673 |
| 94 | sequestering of extracellular ligand from receptor (GO:0035581) | 2.74285840 |
| 95 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.73196129 |
| 96 | regulation of apoptotic cell clearance (GO:2000425) | 2.72756018 |
| 97 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.72649166 |
| 98 | cell wall macromolecule catabolic process (GO:0016998) | 2.72601053 |
| 99 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.71281335 |
| 100 | detection of other organism (GO:0098543) | 2.68938256 |
| 101 | hair cell differentiation (GO:0035315) | 2.67929482 |
| 102 | cellular response to exogenous dsRNA (GO:0071360) | 2.67843790 |
| 103 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.67765376 |
| 104 | protein prenylation (GO:0018342) | 2.67140299 |
| 105 | prenylation (GO:0097354) | 2.67140299 |
| 106 | microglial cell activation (GO:0001774) | 2.66749585 |
| 107 | superoxide anion generation (GO:0042554) | 2.66045268 |
| 108 | urate metabolic process (GO:0046415) | 2.65183461 |
| 109 | estrogen biosynthetic process (GO:0006703) | 2.64278661 |
| 110 | neutrophil mediated immunity (GO:0002446) | 2.64126145 |
| 111 | negative regulation of interleukin-8 production (GO:0032717) | 2.63329219 |
| 112 | cellular response to zinc ion (GO:0071294) | 2.62640778 |
| 113 | positive regulation of leukocyte degranulation (GO:0043302) | 2.62392943 |
| 114 | regulation of antigen processing and presentation (GO:0002577) | 2.60910142 |
| 115 | sphingomyelin metabolic process (GO:0006684) | 2.60672380 |
| 116 | negative regulation of bone resorption (GO:0045779) | 2.60383721 |
| 117 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.59663573 |
| 118 | apoptotic cell clearance (GO:0043277) | 2.59404456 |
| 119 | positive regulation of T cell migration (GO:2000406) | 2.58800560 |
| 120 | zinc ion transport (GO:0006829) | 2.57739768 |
| 121 | intestinal epithelial cell development (GO:0060576) | 2.56849331 |
| 122 | positive regulation of interferon-beta production (GO:0032728) | 2.56036254 |
| 123 | peptide hormone processing (GO:0016486) | 2.55626709 |
| 124 | positive regulation of T cell chemotaxis (GO:0010820) | 2.54375311 |
| 125 | regulation of T cell chemotaxis (GO:0010819) | 2.54375311 |
| 126 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.54134501 |
| 127 | leukotriene metabolic process (GO:0006691) | 2.54041043 |
| 128 | negative regulation of interleukin-12 production (GO:0032695) | 2.54036163 |
| 129 | pinocytosis (GO:0006907) | 2.53426494 |
| 130 | lymphocyte chemotaxis (GO:0048247) | 2.53278278 |
| 131 | ER overload response (GO:0006983) | 2.53063542 |
| 132 | negative regulation of protein autophosphorylation (GO:0031953) | 2.52229216 |
| 133 | T-helper 1 type immune response (GO:0042088) | 2.52107607 |
| 134 | fucose catabolic process (GO:0019317) | 2.52053470 |
| 135 | L-fucose metabolic process (GO:0042354) | 2.52053470 |
| 136 | L-fucose catabolic process (GO:0042355) | 2.52053470 |
| 137 | negative regulation of mast cell activation (GO:0033004) | 2.51834017 |
| 138 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.51380809 |
| 139 | positive regulation of lymphocyte migration (GO:2000403) | 2.50890242 |
| 140 | positive regulation of insulin secretion (GO:0032024) | 2.50564414 |
| 141 | leukocyte aggregation (GO:0070486) | 2.49755186 |
| 142 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.49298256 |
| 143 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.48329974 |
| 144 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.48325885 |
| 145 | cellular response to interferon-beta (GO:0035458) | 2.47787921 |
| 146 | protein K11-linked deubiquitination (GO:0035871) | 2.47606703 |
| 147 | positive regulation of macrophage differentiation (GO:0045651) | 2.46549477 |
| 148 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.46390473 |
| 149 | regulation of monocyte chemotaxis (GO:0090025) | 2.44992698 |
| 150 | regulation of fever generation (GO:0031620) | 2.44950940 |
| 151 | T cell migration (GO:0072678) | 2.44349652 |
| 152 | negative regulation of growth of symbiont in host (GO:0044130) | 2.44328574 |
| 153 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.44328574 |
| 154 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 2.44328574 |
| 155 | regulation of growth of symbiont in host (GO:0044126) | 2.44328574 |
| 156 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.44107113 |
| 157 | response to host (GO:0075136) | 2.44107113 |
| 158 | response to host defenses (GO:0052200) | 2.44107113 |
| 159 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.43647885 |
| 160 | positive regulation of tumor necrosis factor production (GO:0032760) | 2.43290624 |
| 161 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.43241966 |
| 162 | regulation of extracellular matrix disassembly (GO:0010715) | 2.42408218 |
| 163 | nitric oxide mediated signal transduction (GO:0007263) | 2.40912003 |
| 164 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic proc | 2.39297784 |
| 165 | transcytosis (GO:0045056) | 2.39125413 |
| 166 | prostate gland growth (GO:0060736) | 2.37130939 |
| 167 | negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147) | 2.36951467 |
| 168 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.36630638 |
| 169 | retinol metabolic process (GO:0042572) | 2.34401002 |
| 170 | cell wall macromolecule metabolic process (GO:0044036) | 2.33739632 |
| 171 | mesenchymal-epithelial cell signaling (GO:0060638) | 2.32857121 |
| 172 | glandular epithelial cell differentiation (GO:0002067) | 2.31990062 |
| 173 | inner ear receptor cell differentiation (GO:0060113) | 2.31932659 |
| 174 | cytochrome complex assembly (GO:0017004) | 2.31293265 |
| 175 | respiratory chain complex IV assembly (GO:0008535) | 2.31066788 |
| 176 | regulation of execution phase of apoptosis (GO:1900117) | 2.29916641 |
| 177 | negative regulation of hormone biosynthetic process (GO:0032353) | 2.29587567 |
| 178 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.29324441 |
| 179 | parental behavior (GO:0060746) | 2.28288531 |
| 180 | negative regulation of hormone metabolic process (GO:0032351) | 2.28017412 |
| 181 | cellular response to ethanol (GO:0071361) | 2.27995224 |
| 182 | catecholamine biosynthetic process (GO:0042423) | 2.27150810 |
| 183 | catechol-containing compound biosynthetic process (GO:0009713) | 2.27150810 |
| 184 | lactate metabolic process (GO:0006089) | 2.26576484 |
| 185 | positive regulation of peptide hormone secretion (GO:0090277) | 2.23941524 |
| 186 | intra-Golgi vesicle-mediated transport (GO:0006891) | 2.23128786 |
| 187 | hydrogen peroxide catabolic process (GO:0042744) | 2.20983725 |
| 188 | regulation of cellular carbohydrate catabolic process (GO:0043471) | 2.20044163 |
| 189 | regulation of carbohydrate catabolic process (GO:0043470) | 2.20044163 |
| 190 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 2.19854767 |
| 191 | positive regulation of gluconeogenesis (GO:0045722) | 2.18884100 |
| 192 | glucosamine-containing compound catabolic process (GO:1901072) | 2.18548602 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.01792677 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.39764903 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.96210498 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.75408315 |
| 5 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.75135544 |
| 6 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.65996531 |
| 7 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.31956372 |
| 8 | GATA1_22025678_ChIP-Seq_K562_Human | 3.25431102 |
| 9 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.22792906 |
| 10 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.22134932 |
| 11 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.13818067 |
| 12 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.96503758 |
| 13 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.91786952 |
| 14 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.89663011 |
| 15 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.77875539 |
| 16 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.74222872 |
| 17 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.61812445 |
| 18 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.54053852 |
| 19 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.40751252 |
| 20 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.34544275 |
| 21 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.31281097 |
| 22 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.26283419 |
| 23 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.20365624 |
| 24 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.93688303 |
| 25 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.91707145 |
| 26 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.88519038 |
| 27 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.84845499 |
| 28 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.83986596 |
| 29 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.83201498 |
| 30 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.82761898 |
| 31 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.82378127 |
| 32 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.81828962 |
| 33 | * TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.77812853 |
| 34 | * VDR_24787735_ChIP-Seq_THP-1_Human | 1.75304317 |
| 35 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.74312378 |
| 36 | MYB_26560356_Chip-Seq_TH2_Human | 1.74097319 |
| 37 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.72458843 |
| 38 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.70782988 |
| 39 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.65438969 |
| 40 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.63268381 |
| 41 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.57130480 |
| 42 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.57113662 |
| 43 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.53398479 |
| 44 | P300_19829295_ChIP-Seq_ESCs_Human | 1.52515914 |
| 45 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.51441091 |
| 46 | FUS_26573619_Chip-Seq_HEK293_Human | 1.51233937 |
| 47 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.50877885 |
| 48 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.49835655 |
| 49 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.45409515 |
| 50 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.44930743 |
| 51 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.44441140 |
| 52 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.44326534 |
| 53 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.44129440 |
| 54 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.41599905 |
| 55 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.41396423 |
| 56 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.39827943 |
| 57 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 1.37578810 |
| 58 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.35911030 |
| 59 | SPI1_23127762_ChIP-Seq_K562_Human | 1.35878978 |
| 60 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.34328511 |
| 61 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.33742788 |
| 62 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.33681774 |
| 63 | MYB_26560356_Chip-Seq_TH1_Human | 1.33176121 |
| 64 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.31448649 |
| 65 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.30377455 |
| 66 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.30247173 |
| 67 | EWS_26573619_Chip-Seq_HEK293_Human | 1.30132321 |
| 68 | GATA3_26560356_Chip-Seq_TH2_Human | 1.29289183 |
| 69 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.28975820 |
| 70 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.28935960 |
| 71 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.28526040 |
| 72 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.28399041 |
| 73 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.27992024 |
| 74 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.27883639 |
| 75 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.27837784 |
| 76 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.27458910 |
| 77 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.26744871 |
| 78 | * ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.26727234 |
| 79 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.25970139 |
| 80 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.25850229 |
| 81 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.25140267 |
| 82 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.24705957 |
| 83 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.24645660 |
| 84 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.24098393 |
| 85 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.23391559 |
| 86 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.22640351 |
| 87 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.22307384 |
| 88 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.22302315 |
| 89 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.21727150 |
| 90 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.20955626 |
| 91 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.20610749 |
| 92 | STAT3_23295773_ChIP-Seq_U87_Human | 1.19836829 |
| 93 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.19799627 |
| 94 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.19770038 |
| 95 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.19188109 |
| 96 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.18330756 |
| 97 | AR_25329375_ChIP-Seq_VCAP_Human | 1.18211937 |
| 98 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.17930077 |
| 99 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.17577803 |
| 100 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.17423305 |
| 101 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.17223429 |
| 102 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.16712400 |
| 103 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.16654006 |
| 104 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.16310912 |
| 105 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.16310912 |
| 106 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.15243091 |
| 107 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.14200202 |
| 108 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.11840406 |
| 109 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.11763238 |
| 110 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.11763238 |
| 111 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.11055034 |
| 112 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.10689242 |
| 113 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.10654385 |
| 114 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.10654385 |
| 115 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.10227862 |
| 116 | TCF4_23295773_ChIP-Seq_U87_Human | 1.08565198 |
| 117 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.07895706 |
| 118 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.07434866 |
| 119 | * ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.06691552 |
| 120 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.06137575 |
| 121 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.05615418 |
| 122 | MAF_26560356_Chip-Seq_TH1_Human | 1.04902512 |
| 123 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.04743604 |
| 124 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.04677051 |
| 125 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.04534625 |
| 126 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.03325566 |
| 127 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.02674624 |
| 128 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.02582092 |
| 129 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.02566125 |
| 130 | * FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.02343003 |
| 131 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.02063038 |
| 132 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.01899009 |
| 133 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.01449087 |
| 134 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.01139232 |
| 135 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.00510336 |
| 136 | * FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.00020888 |
| 137 | * FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.00020888 |
| 138 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.99488711 |
| 139 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.99082270 |
| 140 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.98648399 |
| 141 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.98614374 |
| 142 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.97359755 |
| 143 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96494923 |
| 144 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.96470760 |
| 145 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.95258881 |
| 146 | GATA2_19941826_ChIP-Seq_K562_Human | 0.92961029 |
| 147 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.86513106 |
| 148 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.85404974 |
| 149 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.83639299 |
| 150 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.80991366 |
| 151 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.80964755 |
| 152 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.80501974 |
| 153 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.80498169 |
| 154 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.80340504 |
| 155 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.80340504 |
| 156 | * WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.79623270 |
| 157 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.79367546 |
| 158 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.79252626 |
| 159 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.78569442 |
| 160 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.76439016 |
| 161 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.74562435 |
| 162 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.73387609 |
| 163 | * EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.73301958 |
| 164 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.73009057 |
| 165 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.72864800 |
| 166 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.72689674 |
| 167 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.72641462 |
| 168 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 0.72504833 |
| 169 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.72229972 |
| 170 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.71913017 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 3.94897869 |
| 2 | MP0003436_decreased_susceptibility_to | 3.70479493 |
| 3 | MP0003724_increased_susceptibility_to | 3.59153620 |
| 4 | MP0001835_abnormal_antigen_presentation | 3.55711572 |
| 5 | MP0002163_abnormal_gland_morphology | 3.16953068 |
| 6 | MP0002148_abnormal_hypersensitivity_rea | 3.05701061 |
| 7 | MP0005058_abnormal_lysosome_morphology | 2.87946266 |
| 8 | MP0003303_peritoneal_inflammation | 2.83598541 |
| 9 | MP0002419_abnormal_innate_immunity | 2.82236487 |
| 10 | MP0001533_abnormal_skeleton_physiology | 2.81855918 |
| 11 | MP0002139_abnormal_hepatobiliary_system | 2.79875056 |
| 12 | MP0001790_abnormal_immune_system | 2.68739102 |
| 13 | MP0005387_immune_system_phenotype | 2.68739102 |
| 14 | MP0005000_abnormal_immune_tolerance | 2.66286653 |
| 15 | MP0009785_altered_susceptibility_to | 2.63614844 |
| 16 | MP0005174_abnormal_tail_pigmentation | 2.62361219 |
| 17 | MP0005025_abnormal_response_to | 2.43585276 |
| 18 | MP0000372_irregular_coat_pigmentation | 2.43382928 |
| 19 | MP0000569_abnormal_digit_pigmentation | 2.30785821 |
| 20 | MP0005671_abnormal_response_to | 2.26904371 |
| 21 | MP0002933_joint_inflammation | 2.23850797 |
| 22 | MP0002254_reproductive_system_inflammat | 2.21470317 |
| 23 | MP0000013_abnormal_adipose_tissue | 2.20558501 |
| 24 | MP0006082_CNS_inflammation | 2.13914151 |
| 25 | MP0008438_abnormal_cutaneous_collagen | 2.13801245 |
| 26 | MP0002877_abnormal_melanocyte_morpholog | 2.12192090 |
| 27 | MP0002452_abnormal_antigen_presenting | 2.11726432 |
| 28 | MP0010234_abnormal_vibrissa_follicle | 2.07707946 |
| 29 | MP0003183_abnormal_peptide_metabolism | 2.06459006 |
| 30 | MP0005220_abnormal_exocrine_pancreas | 2.01809137 |
| 31 | MP0003300_gastrointestinal_ulcer | 1.99727179 |
| 32 | MP0001800_abnormal_humoral_immune | 1.94441594 |
| 33 | MP0003283_abnormal_digestive_organ | 1.92496244 |
| 34 | MP0003950_abnormal_plasma_membrane | 1.91993325 |
| 35 | MP0005075_abnormal_melanosome_morpholog | 1.91039385 |
| 36 | MP0000685_abnormal_immune_system | 1.88439689 |
| 37 | MP0002723_abnormal_immune_serum | 1.88406262 |
| 38 | MP0002998_abnormal_bone_remodeling | 1.85738677 |
| 39 | MP0001819_abnormal_immune_cell | 1.80634958 |
| 40 | MP0002420_abnormal_adaptive_immunity | 1.79099208 |
| 41 | MP0000015_abnormal_ear_pigmentation | 1.77821508 |
| 42 | MP0001845_abnormal_inflammatory_respons | 1.71833297 |
| 43 | MP0002166_altered_tumor_susceptibility | 1.71709352 |
| 44 | MP0005464_abnormal_platelet_physiology | 1.69998831 |
| 45 | MP0001756_abnormal_urination | 1.63371415 |
| 46 | MP0005390_skeleton_phenotype | 1.60675518 |
| 47 | MP0002006_tumorigenesis | 1.60252385 |
| 48 | MP0010329_abnormal_lipoprotein_level | 1.58331944 |
| 49 | MP0002405_respiratory_system_inflammati | 1.58055214 |
| 50 | MP0010155_abnormal_intestine_physiology | 1.54292316 |
| 51 | MP0004947_skin_inflammation | 1.53003547 |
| 52 | MP0003045_fibrosis | 1.49595899 |
| 53 | MP0005367_renal/urinary_system_phenotyp | 1.49526599 |
| 54 | MP0000516_abnormal_urinary_system | 1.49526599 |
| 55 | MP0003191_abnormal_cellular_cholesterol | 1.49265104 |
| 56 | MP0003795_abnormal_bone_structure | 1.48848346 |
| 57 | MP0005332_abnormal_amino_acid | 1.47995964 |
| 58 | MP0000343_altered_response_to | 1.47826837 |
| 59 | MP0002928_abnormal_bile_duct | 1.44203229 |
| 60 | MP0008469_abnormal_protein_level | 1.44130343 |
| 61 | MP0006054_spinal_hemorrhage | 1.42748411 |
| 62 | MP0000003_abnormal_adipose_tissue | 1.42402212 |
| 63 | MP0005646_abnormal_pituitary_gland | 1.41491963 |
| 64 | MP0003172_abnormal_lysosome_physiology | 1.41138600 |
| 65 | MP0004019_abnormal_vitamin_homeostasis | 1.40036656 |
| 66 | MP0004510_myositis | 1.38846652 |
| 67 | MP0009333_abnormal_splenocyte_physiolog | 1.38383017 |
| 68 | MP0009764_decreased_sensitivity_to | 1.37119995 |
| 69 | MP0003252_abnormal_bile_duct | 1.37008455 |
| 70 | MP0005379_endocrine/exocrine_gland_phen | 1.33629835 |
| 71 | MP0003866_abnormal_defecation | 1.32662633 |
| 72 | MP0001542_abnormal_bone_strength | 1.31834151 |
| 73 | MP0002909_abnormal_adrenal_gland | 1.31003125 |
| 74 | MP0009840_abnormal_foam_cell | 1.29452622 |
| 75 | MP0003448_altered_tumor_morphology | 1.29355055 |
| 76 | MP0009780_abnormal_chondrocyte_physiolo | 1.25926747 |
| 77 | MP0002693_abnormal_pancreas_physiology | 1.25723297 |
| 78 | MP0003075_altered_response_to | 1.25373693 |
| 79 | MP0000716_abnormal_immune_system | 1.23293473 |
| 80 | MP0005310_abnormal_salivary_gland | 1.23236544 |
| 81 | MP0003566_abnormal_cell_adhesion | 1.21600090 |
| 82 | MP0004782_abnormal_surfactant_physiolog | 1.21448307 |
| 83 | MP0005171_absent_coat_pigmentation | 1.21194350 |
| 84 | MP0005408_hypopigmentation | 1.20904111 |
| 85 | MP0001853_heart_inflammation | 1.20881305 |
| 86 | MP0005084_abnormal_gallbladder_morpholo | 1.19991444 |
| 87 | MP0002138_abnormal_hepatobiliary_system | 1.19154900 |
| 88 | MP0010678_abnormal_skin_adnexa | 1.18855605 |
| 89 | MP0010352_gastrointestinal_tract_polyps | 1.16262656 |
| 90 | MP0002078_abnormal_glucose_homeostasis | 1.15779718 |
| 91 | MP0002896_abnormal_bone_mineralization | 1.15394599 |
| 92 | MP0002971_abnormal_brown_adipose | 1.15331603 |
| 93 | MP0004484_altered_response_of | 1.13046783 |
| 94 | MP0004808_abnormal_hematopoietic_stem | 1.12488421 |
| 95 | MP0008004_abnormal_stomach_pH | 1.10695208 |
| 96 | MP0005164_abnormal_response_to | 1.09496433 |
| 97 | MP0000465_gastrointestinal_hemorrhage | 1.07323868 |
| 98 | MP0008875_abnormal_xenobiotic_pharmacok | 1.06978611 |
| 99 | MP0003195_calcinosis | 1.06768278 |
| 100 | MP0000858_altered_metastatic_potential | 1.05684399 |
| 101 | MP0005365_abnormal_bile_salt | 1.05588267 |
| 102 | MP0001663_abnormal_digestive_system | 1.05543830 |
| 103 | MP0010386_abnormal_urinary_bladder | 1.03857324 |
| 104 | MP0000427_abnormal_hair_cycle | 1.03726060 |
| 105 | MP0002398_abnormal_bone_marrow | 1.02116666 |
| 106 | MP0005166_decreased_susceptibility_to | 1.01068376 |
| 107 | MP0006072_abnormal_retinal_apoptosis | 0.95035396 |
| 108 | MP0001764_abnormal_homeostasis | 0.94517356 |
| 109 | MP0002429_abnormal_blood_cell | 0.93829473 |
| 110 | MP0005636_abnormal_mineral_homeostasis | 0.93522454 |
| 111 | MP0000371_diluted_coat_color | 0.93243963 |
| 112 | MP0009763_increased_sensitivity_to | 0.92604317 |
| 113 | MP0004134_abnormal_chest_morphology | 0.92500803 |
| 114 | MP0005448_abnormal_energy_balance | 0.91803537 |
| 115 | MP0005645_abnormal_hypothalamus_physiol | 0.91700029 |
| 116 | MP0002876_abnormal_thyroid_physiology | 0.91588352 |
| 117 | MP0001851_eye_inflammation | 0.90790244 |
| 118 | MP0002115_abnormal_skeleton_extremities | 0.90163366 |
| 119 | MP0002118_abnormal_lipid_homeostasis | 0.90069593 |
| 120 | MP0005076_abnormal_cell_differentiation | 0.88201761 |
| 121 | MP0001765_abnormal_ion_homeostasis | 0.87869732 |
| 122 | MP0003953_abnormal_hormone_level | 0.87683507 |
| 123 | MP0005275_abnormal_skin_tensile | 0.87055726 |
| 124 | MP0000639_abnormal_adrenal_gland | 0.86807041 |
| 125 | MP0005389_reproductive_system_phenotype | 0.86236101 |
| 126 | MP0001501_abnormal_sleep_pattern | 0.86069315 |
| 127 | MP0005319_abnormal_enzyme/_coenzyme | 0.84461842 |
| 128 | MP0001873_stomach_inflammation | 0.84080245 |
| 129 | MP0000538_abnormal_urinary_bladder | 0.83862370 |
| 130 | MP0000163_abnormal_cartilage_morphology | 0.83402429 |
| 131 | MP0002113_abnormal_skeleton_development | 0.83051361 |
| 132 | MP0005503_abnormal_tendon_morphology | 0.82714671 |
| 133 | MP0002277_abnormal_respiratory_mucosa | 0.82275264 |
| 134 | MP0008961_abnormal_basal_metabolism | 0.81773173 |
| 135 | MP0000689_abnormal_spleen_morphology | 0.81509572 |
| 136 | MP0005381_digestive/alimentary_phenotyp | 0.81205248 |
| 137 | MP0002938_white_spotting | 0.81020385 |
| 138 | MP0009115_abnormal_fat_cell | 0.80939164 |
| 139 | MP0005085_abnormal_gallbladder_physiolo | 0.80218639 |
| 140 | MP0002168_other_aberrant_phenotype | 0.80198862 |
| 141 | MP0000249_abnormal_blood_vessel | 0.79332953 |
| 142 | MP0002009_preneoplasia | 0.78948471 |
| 143 | MP0002295_abnormal_pulmonary_circulatio | 0.78882196 |
| 144 | MP0003786_premature_aging | 0.78767041 |
| 145 | MP0000383_abnormal_hair_follicle | 0.77922997 |
| 146 | MP0005551_abnormal_eye_electrophysiolog | 0.77434567 |
| 147 | MP0003787_abnormal_imprinting | 0.76815110 |
| 148 | MP0003690_abnormal_glial_cell | 0.75656475 |
| 149 | MP0008057_abnormal_DNA_replication | 0.75222191 |
| 150 | MP0005647_abnormal_sex_gland | 0.75097935 |
| 151 | MP0003279_aneurysm | 0.74777643 |
| 152 | MP0002160_abnormal_reproductive_system | 0.74582171 |
| 153 | MP0005397_hematopoietic_system_phenotyp | 0.74457872 |
| 154 | MP0001545_abnormal_hematopoietic_system | 0.74457872 |
| 155 | MP0004043_abnormal_pH_regulation | 0.73654308 |
| 156 | MP0002722_abnormal_immune_system | 0.73339307 |
| 157 | MP0003186_abnormal_redox_activity | 0.72920882 |
| 158 | MP0002060_abnormal_skin_morphology | 0.72744208 |
| 159 | MP0009384_cardiac_valve_regurgitation | 0.72105251 |
| 160 | MP0005165_increased_susceptibility_to | 0.71442208 |
| 161 | MP0002396_abnormal_hematopoietic_system | 0.71122091 |
| 162 | MP0008877_abnormal_DNA_methylation | 0.70378252 |
| 163 | MP0003763_abnormal_thymus_physiology | 0.70070667 |
| 164 | MP0005535_abnormal_body_temperature | 0.68493534 |
| 165 | MP0001944_abnormal_pancreas_morphology | 0.66211072 |
| 166 | MP0009643_abnormal_urine_homeostasis | 0.66023874 |
| 167 | MP0005023_abnormal_wound_healing | 0.65469234 |
| 168 | MP0003656_abnormal_erythrocyte_physiolo | 0.64469717 |
| 169 | MP0004264_abnormal_extraembryonic_tissu | 0.63256390 |
| 170 | MP0002136_abnormal_kidney_physiology | 0.62469865 |
| 171 | MP0003828_pulmonary_edema | 0.61449772 |
| 172 | MP0000604_amyloidosis | 0.60904124 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Epiphyseal dysplasia (HP:0002656) | 5.55251861 |
| 2 | Irregular epiphyses (HP:0010582) | 4.52932656 |
| 3 | Eczematoid dermatitis (HP:0000976) | 4.51224773 |
| 4 | Systemic lupus erythematosus (HP:0002725) | 4.41150606 |
| 5 | Recurrent abscess formation (HP:0002722) | 4.37966829 |
| 6 | Recurrent bacterial skin infections (HP:0005406) | 4.02861913 |
| 7 | Hyperglycemia (HP:0003074) | 3.92283801 |
| 8 | Cupped ribs (HP:0000887) | 3.85207465 |
| 9 | Large for gestational age (HP:0001520) | 3.79867641 |
| 10 | Vacuolated lymphocytes (HP:0001922) | 3.68960260 |
| 11 | Increased CSF protein (HP:0002922) | 3.68464588 |
| 12 | Hypothermia (HP:0002045) | 3.54405654 |
| 13 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.50172128 |
| 14 | Albinism (HP:0001022) | 3.46126500 |
| 15 | Small epiphyses (HP:0010585) | 3.43614264 |
| 16 | Vitreoretinal degeneration (HP:0000655) | 3.36969471 |
| 17 | Flat acetabular roof (HP:0003180) | 3.34963522 |
| 18 | Congenital sensorineural hearing impairment (HP:0008527) | 3.32135705 |
| 19 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.30918033 |
| 20 | Abnormal tarsal ossification (HP:0008369) | 3.30889046 |
| 21 | Flat capital femoral epiphysis (HP:0003370) | 3.22319762 |
| 22 | Vascular calcification (HP:0004934) | 3.22295176 |
| 23 | Glomerulonephritis (HP:0000099) | 3.17932879 |
| 24 | Hypoplastic ischia (HP:0003175) | 3.17789429 |
| 25 | Metaphyseal cupping (HP:0003021) | 3.15433975 |
| 26 | Dysostosis multiplex (HP:0000943) | 3.13526602 |
| 27 | Cardiovascular calcification (HP:0011915) | 3.12711060 |
| 28 | Cervical subluxation (HP:0003308) | 3.12549623 |
| 29 | Episodic fever (HP:0001954) | 3.04087280 |
| 30 | Hypoglycemic coma (HP:0001325) | 2.98054216 |
| 31 | Abnormal foot bone ossification (HP:0010675) | 2.95280145 |
| 32 | Hematochezia (HP:0002573) | 2.94391089 |
| 33 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.92287026 |
| 34 | Arthropathy (HP:0003040) | 2.91186865 |
| 35 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.89902621 |
| 36 | Cutaneous melanoma (HP:0012056) | 2.86030261 |
| 37 | Abnormality of the vertebral endplates (HP:0005106) | 2.85824578 |
| 38 | Beaking of vertebral bodies (HP:0004568) | 2.85824474 |
| 39 | Abnormality of the ischium (HP:0003174) | 2.81541832 |
| 40 | Delayed epiphyseal ossification (HP:0002663) | 2.80426700 |
| 41 | Myositis (HP:0100614) | 2.80031837 |
| 42 | Metaphyseal dysplasia (HP:0100255) | 2.74435501 |
| 43 | Mucopolysacchariduria (HP:0008155) | 2.74373375 |
| 44 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.74373375 |
| 45 | Conjunctival hamartoma (HP:0100780) | 2.74099389 |
| 46 | Ketoacidosis (HP:0001993) | 2.71466216 |
| 47 | Orchitis (HP:0100796) | 2.70251650 |
| 48 | Abnormality of macrophages (HP:0004311) | 2.65325136 |
| 49 | Periodontitis (HP:0000704) | 2.65059417 |
| 50 | Metaphyseal irregularity (HP:0003025) | 2.62340263 |
| 51 | Osteoarthritis (HP:0002758) | 2.61652444 |
| 52 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.61170915 |
| 53 | Genu varum (HP:0002970) | 2.59440933 |
| 54 | Abnormal pancreas size (HP:0012094) | 2.56684806 |
| 55 | Gingivitis (HP:0000230) | 2.55503233 |
| 56 | Flattened epiphyses (HP:0003071) | 2.54609995 |
| 57 | Ovoid vertebral bodies (HP:0003300) | 2.54324015 |
| 58 | Optic neuritis (HP:0100653) | 2.53307472 |
| 59 | Retrobulbar optic neuritis (HP:0100654) | 2.53307472 |
| 60 | Irregular vertebral endplates (HP:0003301) | 2.52927631 |
| 61 | Obstructive lung disease (HP:0006536) | 2.52821594 |
| 62 | Chronic obstructive pulmonary disease (HP:0006510) | 2.52821594 |
| 63 | Hypoglycemic seizures (HP:0002173) | 2.52643364 |
| 64 | Abnormality of the renal cortex (HP:0011035) | 2.50750995 |
| 65 | Thoracolumbar scoliosis (HP:0002944) | 2.50126800 |
| 66 | Protuberant abdomen (HP:0001538) | 2.48643305 |
| 67 | Abnormality of vitamin B metabolism (HP:0004340) | 2.48207026 |
| 68 | Postural tremor (HP:0002174) | 2.47794019 |
| 69 | Hamartoma of the eye (HP:0010568) | 2.47439731 |
| 70 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.46654860 |
| 71 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.46654860 |
| 72 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.46654860 |
| 73 | Glycosuria (HP:0003076) | 2.46439626 |
| 74 | Abnormality of urine glucose concentration (HP:0011016) | 2.46439626 |
| 75 | Recurrent fungal infections (HP:0002841) | 2.45720037 |
| 76 | Recurrent skin infections (HP:0001581) | 2.45263432 |
| 77 | Abnormality of the lumbar spine (HP:0100712) | 2.44844381 |
| 78 | Hypokinesia (HP:0002375) | 2.44691910 |
| 79 | Abnormality of complement system (HP:0005339) | 2.41936809 |
| 80 | Loss of speech (HP:0002371) | 2.40831888 |
| 81 | Enlarged epiphyses (HP:0010580) | 2.40253518 |
| 82 | Abnormality of femoral epiphyses (HP:0006499) | 2.38840626 |
| 83 | Abnormality involving the epiphyses of the lower limbs (HP:0006500) | 2.38840626 |
| 84 | Autoimmune thrombocytopenia (HP:0001973) | 2.38680589 |
| 85 | Platyspondyly (HP:0000926) | 2.35153075 |
| 86 | Tongue fasciculations (HP:0001308) | 2.31952490 |
| 87 | Prostate neoplasm (HP:0100787) | 2.28027277 |
| 88 | Hypoplasia of the fovea (HP:0007750) | 2.27221357 |
| 89 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.27221357 |
| 90 | Mediastinal lymphadenopathy (HP:0100721) | 2.26263816 |
| 91 | Intestinal atresia (HP:0011100) | 2.25592062 |
| 92 | Abnormality of glycolipid metabolism (HP:0010969) | 2.24813091 |
| 93 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.24813091 |
| 94 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.24813091 |
| 95 | Recurrent viral infections (HP:0004429) | 2.23293611 |
| 96 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.21920717 |
| 97 | Neonatal short-limb short stature (HP:0008921) | 2.21678893 |
| 98 | Renal cortical cysts (HP:0000803) | 2.21569393 |
| 99 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 2.20599158 |
| 100 | Hemiparesis (HP:0001269) | 2.20454671 |
| 101 | Exocrine pancreatic insufficiency (HP:0001738) | 2.19768222 |
| 102 | Coxa vara (HP:0002812) | 2.18371703 |
| 103 | Abnormality of the epiphysis of the femoral head (HP:0010574) | 2.18006813 |
| 104 | Mild short stature (HP:0003502) | 2.17163010 |
| 105 | Abnormality of the femoral head (HP:0003368) | 2.16642740 |
| 106 | Orthostatic hypotension (HP:0001278) | 2.16605746 |
| 107 | Absent frontal sinuses (HP:0002688) | 2.15341415 |
| 108 | Widely spaced teeth (HP:0000687) | 2.15154791 |
| 109 | Abnormal vertebral ossification (HP:0100569) | 2.14573772 |
| 110 | Abnormal drinking behavior (HP:0030082) | 2.13437706 |
| 111 | Polydipsia (HP:0001959) | 2.13437706 |
| 112 | Disproportionate short-trunk short stature (HP:0003521) | 2.12924600 |
| 113 | Stomatitis (HP:0010280) | 2.12873887 |
| 114 | Increased cerebral lipofuscin (HP:0011813) | 2.12578849 |
| 115 | Progressive neurologic deterioration (HP:0002344) | 2.12327628 |
| 116 | Spondylolisthesis (HP:0003302) | 2.12313150 |
| 117 | Prolonged bleeding time (HP:0003010) | 2.09725046 |
| 118 | Bone cyst (HP:0012062) | 2.09160850 |
| 119 | Vertebral compression fractures (HP:0002953) | 2.07854588 |
| 120 | Muscle fibrillation (HP:0010546) | 2.05803412 |
| 121 | Hyperventilation (HP:0002883) | 2.05633528 |
| 122 | Tetraparesis (HP:0002273) | 2.05042226 |
| 123 | J-shaped sella turcica (HP:0002680) | 2.03543347 |
| 124 | Testicular neoplasm (HP:0010788) | 2.03173012 |
| 125 | Pulmonary infiltrates (HP:0002113) | 2.02005066 |
| 126 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.02003658 |
| 127 | Abnormality of carpal bone ossification (HP:0006257) | 2.01486121 |
| 128 | Spinal cord compression (HP:0002176) | 2.01306053 |
| 129 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.00947462 |
| 130 | Vasculitis (HP:0002633) | 2.00347051 |
| 131 | Gastrointestinal infarctions (HP:0005244) | 1.99428668 |
| 132 | Sensory axonal neuropathy (HP:0003390) | 1.99399612 |
| 133 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 1.99154171 |
| 134 | Joint stiffness (HP:0001387) | 1.99081159 |
| 135 | Patchy hypopigmentation of hair (HP:0011365) | 1.97952344 |
| 136 | Hypoplasia of the odontoid process (HP:0003311) | 1.96431905 |
| 137 | Vertebral hypoplasia (HP:0008417) | 1.96323687 |
| 138 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 1.96323687 |
| 139 | Peritonitis (HP:0002586) | 1.96147657 |
| 140 | Gaze-evoked nystagmus (HP:0000640) | 1.95954435 |
| 141 | Thoracic kyphosis (HP:0002942) | 1.94836214 |
| 142 | Thick nail (HP:0001805) | 1.94151274 |
| 143 | Abnormal sex determination (HP:0012244) | 1.93840331 |
| 144 | Sex reversal (HP:0012245) | 1.93840331 |
| 145 | Petechiae (HP:0000967) | 1.93775911 |
| 146 | Abnormality of the frontal sinuses (HP:0002687) | 1.93235553 |
| 147 | Attenuation of retinal blood vessels (HP:0007843) | 1.92057255 |
| 148 | White forelock (HP:0002211) | 1.92003004 |
| 149 | Nephritis (HP:0000123) | 1.91361443 |
| 150 | Ketosis (HP:0001946) | 1.90712173 |
| 151 | Proximal tubulopathy (HP:0000114) | 1.90379201 |
| 152 | Congenital stationary night blindness (HP:0007642) | 1.89464327 |
| 153 | Abnormality of vitamin metabolism (HP:0100508) | 1.89056468 |
| 154 | Tubular atrophy (HP:0000092) | 1.89035738 |
| 155 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.89021488 |
| 156 | Osteolytic defects of the hand bones (HP:0009699) | 1.89021488 |
| 157 | Abnormality of the common coagulation pathway (HP:0010990) | 1.88779207 |
| 158 | Pustule (HP:0200039) | 1.88231988 |
| 159 | Complement deficiency (HP:0004431) | 1.87839249 |
| 160 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.87344272 |
| 161 | Urethral obstruction (HP:0000796) | 1.86755768 |
| 162 | Late onset (HP:0003584) | 1.85969584 |
| 163 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.85309256 |
| 164 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.85309256 |
| 165 | Furrowed tongue (HP:0000221) | 1.85254170 |
| 166 | Follicular hyperkeratosis (HP:0007502) | 1.84978522 |
| 167 | Congenital malformation of the right heart (HP:0011723) | 1.84805608 |
| 168 | Double outlet right ventricle (HP:0001719) | 1.84805608 |
| 169 | Hypergonadotropic hypogonadism (HP:0000815) | 1.84714599 |
| 170 | Abnormal albumin level (HP:0012116) | 1.82675744 |
| 171 | Hypoalbuminemia (HP:0003073) | 1.82675744 |
| 172 | Gingival bleeding (HP:0000225) | 1.82184363 |
| 173 | Mesangial abnormality (HP:0001966) | 1.82030696 |
| 174 | Enlarged penis (HP:0000040) | 1.78796672 |
| 175 | Aplasia/Hypoplasia of the macula (HP:0008059) | 1.77260027 |
| 176 | Acute myeloid leukemia (HP:0004808) | 1.77166660 |
| 177 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.75097527 |
| 178 | Abnormality of renal excretion (HP:0011036) | 1.73361446 |
| 179 | Thyroiditis (HP:0100646) | 1.71819487 |
| 180 | Progressive macrocephaly (HP:0004481) | 1.71303413 |
| 181 | Mitral stenosis (HP:0001718) | 1.71025552 |
| 182 | Type I diabetes mellitus (HP:0100651) | 1.70636703 |
| 183 | Cardiomegaly (HP:0001640) | 1.70105065 |
| 184 | Constricted visual fields (HP:0001133) | 1.68899860 |
| 185 | Abnormal biliary tract morphology (HP:0012440) | 1.66815284 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TAOK3 | 5.05129952 |
| 2 | IRAK3 | 3.30615272 |
| 3 | MAP3K14 | 3.25120957 |
| 4 | IRAK4 | 3.16895171 |
| 5 | BLK | 2.68968476 |
| 6 | MAP4K2 | 2.51212834 |
| 7 | TRIM28 | 2.49692028 |
| 8 | ERN1 | 2.43752786 |
| 9 | FER | 2.35068900 |
| 10 | TYK2 | 2.33316455 |
| 11 | MST1R | 2.32628948 |
| 12 | MST4 | 2.26940630 |
| 13 | TBK1 | 2.22149874 |
| 14 | TXK | 2.18966032 |
| 15 | FGFR2 | 2.11404257 |
| 16 | GRK1 | 2.11253822 |
| 17 | PIM2 | 2.08448617 |
| 18 | JAK1 | 2.06975624 |
| 19 | INSRR | 2.03968225 |
| 20 | MAP3K3 | 1.93496044 |
| 21 | DAPK2 | 1.92601922 |
| 22 | TEC | 1.88990963 |
| 23 | STK24 | 1.88814586 |
| 24 | ACVR1B | 1.84067661 |
| 25 | MAP4K1 | 1.80611217 |
| 26 | STK39 | 1.73902416 |
| 27 | PAK3 | 1.71716403 |
| 28 | IKBKE | 1.70712905 |
| 29 | ADRBK2 | 1.68276639 |
| 30 | PDK2 | 1.67901373 |
| 31 | EPHB1 | 1.66284953 |
| 32 | EPHA3 | 1.62002138 |
| 33 | JAK3 | 1.59627198 |
| 34 | AKT3 | 1.59047073 |
| 35 | PNCK | 1.53985728 |
| 36 | RIPK4 | 1.52434585 |
| 37 | LMTK2 | 1.50928332 |
| 38 | IRAK1 | 1.49373506 |
| 39 | NUAK1 | 1.46797461 |
| 40 | WNK3 | 1.44632912 |
| 41 | TGFBR2 | 1.43526954 |
| 42 | CSK | 1.43103892 |
| 43 | IKBKB | 1.43074431 |
| 44 | KIT | 1.42224737 |
| 45 | ZAP70 | 1.35090710 |
| 46 | PHKG2 | 1.30473640 |
| 47 | PHKG1 | 1.30473640 |
| 48 | TRPM7 | 1.30231945 |
| 49 | FRK | 1.22820078 |
| 50 | PIK3CG | 1.19789760 |
| 51 | ITK | 1.18842391 |
| 52 | FGFR3 | 1.18371570 |
| 53 | BTK | 1.18348001 |
| 54 | GRK7 | 1.13867318 |
| 55 | MKNK2 | 1.11719350 |
| 56 | TAOK1 | 1.11185563 |
| 57 | HIPK2 | 1.07336597 |
| 58 | STK38L | 1.07280632 |
| 59 | CLK1 | 1.05715428 |
| 60 | RIPK1 | 1.04106186 |
| 61 | MAP2K6 | 1.04000755 |
| 62 | TNIK | 1.03356004 |
| 63 | JAK2 | 0.98362943 |
| 64 | NEK9 | 0.97412695 |
| 65 | BMPR1B | 0.97330781 |
| 66 | CHUK | 0.97275378 |
| 67 | PRKG2 | 0.95085290 |
| 68 | STK10 | 0.92180607 |
| 69 | OXSR1 | 0.91702860 |
| 70 | NLK | 0.91135847 |
| 71 | LYN | 0.88642854 |
| 72 | TNK2 | 0.87876996 |
| 73 | PLK2 | 0.87848861 |
| 74 | PBK | 0.87478021 |
| 75 | STK3 | 0.87164700 |
| 76 | PTK2B | 0.85294049 |
| 77 | BMPR2 | 0.85031005 |
| 78 | FGFR4 | 0.84778674 |
| 79 | SYK | 0.84262582 |
| 80 | PIM1 | 0.83915791 |
| 81 | LCK | 0.83161524 |
| 82 | MAP3K12 | 0.81784698 |
| 83 | ZAK | 0.81525959 |
| 84 | EIF2AK2 | 0.80530556 |
| 85 | HCK | 0.79044211 |
| 86 | FLT3 | 0.78933186 |
| 87 | MYLK | 0.76783929 |
| 88 | WNK4 | 0.75899549 |
| 89 | DDR2 | 0.75695680 |
| 90 | BRSK2 | 0.75654407 |
| 91 | MAP3K2 | 0.74781623 |
| 92 | CAMK2D | 0.74220009 |
| 93 | CAMK1D | 0.73145499 |
| 94 | ADRBK1 | 0.72493131 |
| 95 | MATK | 0.69850463 |
| 96 | PRKCI | 0.68653485 |
| 97 | MAPK15 | 0.67565149 |
| 98 | PRKAA2 | 0.67052707 |
| 99 | RPS6KA4 | 0.67051274 |
| 100 | PIK3CA | 0.65690871 |
| 101 | PRKD2 | 0.65624267 |
| 102 | SCYL2 | 0.63830984 |
| 103 | IRAK2 | 0.60545503 |
| 104 | ERBB3 | 0.60490165 |
| 105 | MARK3 | 0.60052236 |
| 106 | MET | 0.57988869 |
| 107 | RPS6KA6 | 0.57975074 |
| 108 | EIF2AK3 | 0.57569351 |
| 109 | GRK6 | 0.56886844 |
| 110 | MAP2K3 | 0.56736325 |
| 111 | RPS6KL1 | 0.56395296 |
| 112 | RPS6KC1 | 0.56395296 |
| 113 | MAP3K1 | 0.56036612 |
| 114 | MAP3K13 | 0.54589733 |
| 115 | CSF1R | 0.53142323 |
| 116 | PTK6 | 0.52483533 |
| 117 | MKNK1 | 0.52013153 |
| 118 | FES | 0.50498825 |
| 119 | CDK6 | 0.49436377 |
| 120 | IGF1R | 0.47390466 |
| 121 | PRKAA1 | 0.46883582 |
| 122 | ABL2 | 0.46743892 |
| 123 | STK11 | 0.46120934 |
| 124 | CAMKK2 | 0.45643343 |
| 125 | PRKCQ | 0.44746201 |
| 126 | MAP2K1 | 0.43165774 |
| 127 | GSK3A | 0.42100240 |
| 128 | PRKCD | 0.41621151 |
| 129 | ROCK1 | 0.39812321 |
| 130 | MAP3K5 | 0.38476015 |
| 131 | YES1 | 0.37963748 |
| 132 | EGFR | 0.37597700 |
| 133 | DYRK1B | 0.35933939 |
| 134 | PINK1 | 0.35931530 |
| 135 | PRKD1 | 0.34959329 |
| 136 | ABL1 | 0.34873320 |
| 137 | CDK9 | 0.34794795 |
| 138 | PRKCE | 0.34372510 |
| 139 | MAPKAPK2 | 0.33854258 |
| 140 | RPS6KA2 | 0.33301518 |
| 141 | MAP3K4 | 0.30857183 |
| 142 | NME2 | 0.30718788 |
| 143 | MUSK | 0.30618342 |
| 144 | NME1 | 0.30347424 |
| 145 | CAMK1G | 0.29993903 |
| 146 | STK4 | 0.29721736 |
| 147 | BMX | 0.28943673 |
| 148 | DMPK | 0.28311363 |
| 149 | RPS6KA5 | 0.28270422 |
| 150 | CDK3 | 0.26904613 |
| 151 | PRKACB | 0.23217349 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.39617122 |
| 2 | Other glycan degradation_Homo sapiens_hsa00511 | 3.07515183 |
| 3 | Leishmaniasis_Homo sapiens_hsa05140 | 2.68089446 |
| 4 | Protein export_Homo sapiens_hsa03060 | 2.66015140 |
| 5 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.34877628 |
| 6 | Pertussis_Homo sapiens_hsa05133 | 2.27818388 |
| 7 | Legionellosis_Homo sapiens_hsa05134 | 2.20457435 |
| 8 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.13463816 |
| 9 | Lysosome_Homo sapiens_hsa04142 | 2.11171586 |
| 10 | Asthma_Homo sapiens_hsa05310 | 2.04630855 |
| 11 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.04400211 |
| 12 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.01267023 |
| 13 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.99878502 |
| 14 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.99143116 |
| 15 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.96664412 |
| 16 | Malaria_Homo sapiens_hsa05144 | 1.93920361 |
| 17 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.86641828 |
| 18 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.83932470 |
| 19 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.80798821 |
| 20 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.77031372 |
| 21 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.76450845 |
| 22 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.75105732 |
| 23 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.74753286 |
| 24 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.74361739 |
| 25 | Phagosome_Homo sapiens_hsa04145 | 1.71370641 |
| 26 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.69976172 |
| 27 | Measles_Homo sapiens_hsa05162 | 1.66454103 |
| 28 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.63157521 |
| 29 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.62504614 |
| 30 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.60738618 |
| 31 | Tuberculosis_Homo sapiens_hsa05152 | 1.59542181 |
| 32 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.59125800 |
| 33 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.54632939 |
| 34 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.52699266 |
| 35 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.49028375 |
| 36 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.48163926 |
| 37 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.47200409 |
| 38 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.46659824 |
| 39 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.43059557 |
| 40 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.42566935 |
| 41 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.42116990 |
| 42 | Allograft rejection_Homo sapiens_hsa05330 | 1.41566001 |
| 43 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.38762995 |
| 44 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.37694165 |
| 45 | Insulin secretion_Homo sapiens_hsa04911 | 1.34866438 |
| 46 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.33944460 |
| 47 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.31395756 |
| 48 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.31020841 |
| 49 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.28990835 |
| 50 | Influenza A_Homo sapiens_hsa05164 | 1.28194106 |
| 51 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.27076912 |
| 52 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.26923994 |
| 53 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.26484925 |
| 54 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.24440070 |
| 55 | Peroxisome_Homo sapiens_hsa04146 | 1.19917374 |
| 56 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.18089168 |
| 57 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.16393115 |
| 58 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.13901089 |
| 59 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.13506765 |
| 60 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.12087756 |
| 61 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.11918471 |
| 62 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.10067610 |
| 63 | Salmonella infection_Homo sapiens_hsa05132 | 1.08956824 |
| 64 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.07705094 |
| 65 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.07029219 |
| 66 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.05246185 |
| 67 | Phototransduction_Homo sapiens_hsa04744 | 1.00993725 |
| 68 | Retinol metabolism_Homo sapiens_hsa00830 | 0.99209961 |
| 69 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.96963569 |
| 70 | Hepatitis C_Homo sapiens_hsa05160 | 0.96554286 |
| 71 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.95130147 |
| 72 | Apoptosis_Homo sapiens_hsa04210 | 0.92952058 |
| 73 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.92528436 |
| 74 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.92095686 |
| 75 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.91947816 |
| 76 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.91123836 |
| 77 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.90912541 |
| 78 | Galactose metabolism_Homo sapiens_hsa00052 | 0.88150331 |
| 79 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.87961862 |
| 80 | Hepatitis B_Homo sapiens_hsa05161 | 0.87815235 |
| 81 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.87660480 |
| 82 | Circadian rhythm_Homo sapiens_hsa04710 | 0.86516547 |
| 83 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.86450665 |
| 84 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.86291552 |
| 85 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.86254899 |
| 86 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.85598794 |
| 87 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.84688481 |
| 88 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.84456151 |
| 89 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.83704953 |
| 90 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.83274034 |
| 91 | Amoebiasis_Homo sapiens_hsa05146 | 0.82906643 |
| 92 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.81010156 |
| 93 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.79690120 |
| 94 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.79684415 |
| 95 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.74987778 |
| 96 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.74986854 |
| 97 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.72289370 |
| 98 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.70873060 |
| 99 | Renin secretion_Homo sapiens_hsa04924 | 0.68804168 |
| 100 | Mineral absorption_Homo sapiens_hsa04978 | 0.68333777 |
| 101 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.67834618 |
| 102 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.67587517 |
| 103 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.66884350 |
| 104 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.65423036 |
| 105 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.64881031 |
| 106 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.62249735 |
| 107 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.60301404 |
| 108 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.59808366 |
| 109 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.58573339 |
| 110 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.57764965 |
| 111 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.57227254 |
| 112 | Viral myocarditis_Homo sapiens_hsa05416 | 0.57102864 |
| 113 | Prion diseases_Homo sapiens_hsa05020 | 0.55825252 |
| 114 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.55794320 |
| 115 | Platelet activation_Homo sapiens_hsa04611 | 0.55451259 |
| 116 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.55254174 |
| 117 | Insulin resistance_Homo sapiens_hsa04931 | 0.54796242 |
| 118 | Shigellosis_Homo sapiens_hsa05131 | 0.53984394 |
| 119 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.53866543 |
| 120 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.53639506 |
| 121 | ABC transporters_Homo sapiens_hsa02010 | 0.53436160 |
| 122 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.53094319 |
| 123 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.52046132 |
| 124 | Histidine metabolism_Homo sapiens_hsa00340 | 0.50423287 |
| 125 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.48863296 |
| 126 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.48637018 |
| 127 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.47543629 |
| 128 | Metabolic pathways_Homo sapiens_hsa01100 | 0.47380407 |
| 129 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.47050373 |
| 130 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.44603720 |
| 131 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.43601350 |
| 132 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.41558108 |
| 133 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.41493701 |
| 134 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.41026738 |
| 135 | Focal adhesion_Homo sapiens_hsa04510 | 0.40975977 |
| 136 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.40730175 |
| 137 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.39913274 |
| 138 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.39731887 |
| 139 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.39501613 |
| 140 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.39303448 |
| 141 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.36891835 |
| 142 | Salivary secretion_Homo sapiens_hsa04970 | 0.36696886 |
| 143 | Melanoma_Homo sapiens_hsa05218 | 0.34503466 |
| 144 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.34197750 |
| 145 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.33871170 |
| 146 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.32967912 |
| 147 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.32037037 |
| 148 | Prostate cancer_Homo sapiens_hsa05215 | 0.31136999 |
| 149 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.30037350 |
| 150 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.30018301 |
| 151 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.27779656 |
| 152 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.25403671 |

